You are here: Industry Insights > Nasdaq

News List

PharmaCyte Biotech Announces Uplist to The Nasdaq Capital Market and Launch of Public Offering firstwordpharma
August 03, 2021
PharmaCyte Biotech, Inc. (OTCQB: PMCBD) (PharmaCyte or Company) today announced that The Nasdaq Stock Market LLC (Nasdaq) has approved the listing of the Company's common stock on Nasdaq.
Brazil to buy single-shot Chinese COVID-19 vaccine PharmaSources
June 17, 2021
According to a negotiation document, Brazil plans to purchase 60 million doses of the single-shot COVID-19 vaccine developed by China's CanSino Biologics for delivery in the third and fourth quarters of this year, as reported by NASDAQ.
Field Trip Health Ltd. Applies to List Its Common Shares on the NASDAQ Stock Market firstwordpharma
June 09, 2021
Field Trip Health Ltd. (TSX: FTRP; FTRP.WT; OTCQX: FTRPF) ("Field Trip"), a leader in the development and delivery of psychedelic therapies, is pleased to announce that it has applied to list its common shares (the “Common Shares”)
China Biologic Announces Completion of Going Private Transaction prnasia
April 21, 2021
China Biologic Products Holdings, Inc., a leading fully integrated plasma-based biopharmaceutical company in China, today announced the completion of its merger with CBPO Group Limited, a wholly owned subsidiary of CBPO Holdings Limited , pursuant to ...
China Jo-Jo Drugstores Regains Compliance with Nasdaq Minimum Bid Price Requirement prnasia
December 24, 2020
China Jo-Jo Drugstores, Inc., a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, announced that it has received notification from the Listing Qualifications ...
I-Mab Added to Nasdaq Biotechnology Index prnasia
December 15, 2020
I-Mab announced that I-Mab's American Depositary Shares (ADS) have been selected for inclusion in the NASDAQ Biotechnology Index, based on the results of the annual reconstitution of the index announced by Nasdaq on December 11, 2020.
Lianluo Smart Announces Receipt of Nasdaq Non-compliance of Stockholders' Equity Notification prnasia
January 06, 2020
The notification of noncompliance has no immediate effect on the listing or trading of the Company's common shares on the Nasdaq Capital Market.
China unveils final rules for Nasdaq-style high-tech board fiercepharma
March 11, 2019
China’s securities authorities released final rules for the country’s new Nasdaq-style high-tech board, which could compete with Hong Kong, S.A.R., China and New York for listing of China-based tech companies, including biotechs.
Biofrontera cleared of wrongdoing in Nasdaq IPO fiercebiotech
December 26, 2018
An independent review has cleared Biofrontera of wrongdoing related to its U.S. IPO. Shareholders had accused Biofrontera of acting contrary to its duties when it priced and sold stock in the U.S.....
Biostar Regains Compliance with NASDAQ Continued Listing Requirement prnasia
December 06, 2017
Biostar Pharmaceuticals, Inc., a Chinese pharmaceutical and healthcare marketer based in China, announced that it received a letter from a Nasdaq-listed employee on November 30, 2017

Previous page 1 2 Next page